Related Experiment Video

Updated: Jun 27, 2026

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry
10:24

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry

Published on: October 28, 2014

Hypokalemia with hypercalcemia. Prevalence and significance in treatment

K A Aldinger, N A Samaan

    Annals of Internal Medicine
    |November 1, 1977
    PubMed

    Insights

    Hypokalemia, or low potassium, is common in hypercalcemia patients. This study found 32% of patients had hypokalemia, especially those with cancer, highlighting the need for careful treatment.

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Nephrology

    Background:

    • Hypokalemia (low potassium) is a serious complication in patients with hypercalcemia (high calcium).
    • Understanding the prevalence of hypokalemia in hypercalcemia is crucial for patient management.
    • Hypercalcemia can lead to various electrolyte imbalances, including potassium deficiency.

    Purpose of the Study:

    • To determine the prevalence of hypokalemia in a cohort of patients with hypercalcemia.
    • To investigate the association between hypercalcemia severity and hypokalemia.
    • To compare hypokalemia prevalence in different etiologies of hypercalcemia.

    Main Methods:

    • Retrospective analysis of 103 patients with hypercalcemia and normal renal function.
    • Exclusion of patients on potassium-depleting medications.
    • Assessment of serum potassium and calcium levels.

    Main Results:

    • 32% of hypercalcemia patients (33 out of 103) exhibited hypokalemia.
    • Hypokalemia prevalence was significantly higher in malignancy-associated hypercalcemia (52.3%) versus primary hyperparathyroidism (16.9%).
    • Higher serum calcium levels correlated with increased frequency and severity of hypokalemia.

    Conclusions:

    • Hypokalemia is a frequent biochemical abnormality in patients with hypercalcemia.
    • The risk of hypokalemia is elevated in malignancy-related hypercalcemia.
    • Careful monitoring and consideration of potassium levels are essential during hypercalcemia treatment, particularly when using diuretics.

    More Related Videos

    A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

    A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

    Published on: June 2, 2022

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    Related Concept Videos

    Skeleton and Calcium Homeostasis01:21

    Skeleton and Calcium Homeostasis

    Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
    Synthesis and Functions of Calcitonin00:51

    Synthesis and Functions of Calcitonin

    Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
    The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
    Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

    Antihypertensive Drugs: Potassium-Sparing Diuretics

    Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Hyperthyroidism II: Pathophysiology01:27

    Hyperthyroidism II: Pathophysiology

    Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...